Ascorutin (ascorbic acid) tablets №50

active ingredients: ascorbic acid (vitamin C), rutoside;

1 tablet contains ascorbic acid (vitamin C) in terms of 100% substance
50 mg; rutoside trihydrate in terms of 100% anhydrous substance 50 mg;

excipients: white sugar, potato starch, corn starch, magnesium stearate, talc.

Pills.

Basic physical and chemical properties: single-layer tablets, round in shape, light yellow with a greenish tinge in color, the upper and lower surfaces of which are flat, the edges of the surfaces are bevelled. Inclusions are allowed on the surface of the tablets. A relatively homogeneous structure can be seen on the fault under a magnifying glass.

capillary stabilizing agents. Bioflavonoids. Rutozid, combinations. ATX code C05C A51.

Combined drug, the action of which is due to the effects of the components that make up its composition.

Rutoside (vitamin P) promotes the conversion of ascorbic acid into dehydroascorbic acid and prevents further transformation of the latter into diketogulonic acid. Therefore, most of the effects of rutoside are indirectly through ascorbic acid.

Rutoside in combination with ascorbic acid reduces capillary permeability and fragility, strengthens the cell wall, reduces platelet aggregation, has an anti-inflammatory effect (including due to inhibition of hyaluronidase activity), antioxidant properties, takes part in redox processes.

In addition, rutoside is characterized by such effects as a decrease in the exudation of the liquid part of the blood plasma and diapedesis of blood cells through the vascular wall; choleretic and mild antihypertensive effects.

In patients with chronic venous insufficiency, rutozide leads to a decrease in edema and pain syndromes, trophic disorders, a decrease or disappearance of paresthesias and convulsions. It helps to reduce the severity of side effects of radiation therapy (cystitis, enteroproctitis, dysphagia, skin erythema), and also slows down the progression of diabetic retinopathy.